Ibandronate: efficient in managing lung cancer associated hypercalcaemia

A. G. Charpidou, I. Danos, G. Dionellis, N. Philippou, N. Georgatou, H. Lambrakis, K. N. Syrigos (Athens, Greece)

Source: Annual Congress 2003 - Cancer and complications
Session: Cancer and complications
Session type: Thematic Poster Session
Number: 2770

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. G. Charpidou, I. Danos, G. Dionellis, N. Philippou, N. Georgatou, H. Lambrakis, K. N. Syrigos (Athens, Greece). Ibandronate: efficient in managing lung cancer associated hypercalcaemia. Eur Respir J 2003; 22: Suppl. 45, 2770

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Are biphosphonates efficient in the adjuvant treatment of lung cancer?
Source: Eur Respir J 2006; 28: Suppl. 50, 754s
Year: 2006

Mianserin therapy in advanced lung cancer patients
Source: Eur Respir J 2002; 20: Suppl. 38, 367s
Year: 2002

Characteristics, incidence, risk factors, and practical management of pneumonitis associated with anti-PD-1 immunotherapy in patients with non-small cell lung cancer
Source: International Congress 2019 – Treatment of lung cancer
Year: 2019

The role of bisphosphonates in lung cancer patients with bone metastases
Source: Annual Congress 2007 - Therapeutic approaches in thoracic oncology
Year: 2007


Treatment and prognosis of lung cancer associated with interstitial pneumonia
Source: Annual Congress 2010 - Thoracic malignancies: interesting case studies and series
Year: 2010


Management of concomitant COPD in patients with lung cancer
Source: International Congress 2018 – Lung cancer: personalised medicine
Year: 2018

Lung disease induced by newer therapies for lung cancer: an update
Source: Annual Congress 2006 - Drug-induced lung injury – new aspects
Year: 2006


Successful targeted therapy of advanced lung cancer
Source: Annual Congress 2013 –Grand Round on diagnostic and therapeutic challenges in thoracic oncology: an interactive session
Year: 2013


Management of lung cancer in the elderly
Source: Eur Respir J 2006; 28: Suppl. 50, 751s
Year: 2006

Nonsurgical treatment of recurrent lung cancer
Source: Annual Congress 2007 - Recurrence of lung cancer following resection with curative intent
Year: 2007


Biphosphonate, ibantronate improves analgesic therapy in non-small lung cancer (NSCLC) patients with bone metastases
Source: Eur Respir J 2005; 26: Suppl. 49, 326s
Year: 2005

Pancreatic polypeptide is increased in patients with advanced malignant disease including lung cancer
Source: Eur Respir J 2002; 20: Suppl. 38, 232s
Year: 2002

Effectiveness of chemotherapy for advanced lung cancer in the elderly
Source: Annual Congress 2009 - Management of thoracic malignancies
Year: 2009

Immune-checkpoint inhibitors associated with interstitial lung disease in cancer patients
Source: Eur Respir J, 50 (2) 1700050; 10.1183/13993003.00050-2017
Year: 2017



Lung nodules in a lung cancer screening program: incidence density of lung cancer in patients with COPD and/or emphysema
Source: Annual Congress 2009 - Epidemiology and management of lung cancer
Year: 2009


Clonality of multifocal nonsmall cell lung cancer: implications for staging and therapy
Source: Eur Respir J 2012; 39: 1437-1442
Year: 2012



Locally advanced and metastatic lung cancer management delay: Tunisian department experience
Source: International Congress 2016 – Quality management and quality of life in lung cancer
Year: 2016


Eosinophilia in lung cancer patients treated with immunotherapy
Source: International Congress 2019 – Symptoms, risks, complications and palliative care in thoracic oncology
Year: 2019

The primary prevention of lung cancer
Source: European Multidisciplinary Conference in Thoracic Oncology 2009
Year: 2009